This Article contains errors in the Acknowledgements section: "Abbott Vascular Int. (2011-2014), Amgen (2012-2018), AstraZeneca (2014-2017), Bayer (2013-2018), Boehringer Ingelheim (2013-2016), Boston Scientific (2010-2012), The Bristol Myers Squibb and Pfizer Alliance (2014-2016), The Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company (2014-2017), Gedeon Richter Plc. (2014-2017), Menarini Int. Op. (2010-2012), MSD-Merck & Co. (2011-2014), Novartis Pharma AG (2014-2017), ResMed (2014-2016), Sanofi (2010-2011), SERVIER (2012-2018)". should read: "Abbott Vascular Int. (2011-2014), Amgen (2009-2018), AstraZeneca (2014-2017), Bayer (2009-2018), Boehringer Ingelheim (2009-2016), Boston Scientific (2009-2012), The Bristol Myers Squibb and Pfizer Alliance (2011-2016), The Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company (2011-2017), Gedeon Richter Plc. (2014-2017), Menarini Int. Op. (2009-2012), MSD-Merck & Co. (2011-2014), Novartis Pharma AG (2014-2017), ResMed (2014-2016), Sanofi (2009-2011), SERVIER (2009-2018)".
Corrigendum: Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes (Scientific Reports (2016) 6 (30271) DOI: 10.1038/srep30271) / Boriani, Giuseppe; Laroche, Cécile; Diemberger, Igor; Popescu, Mircea Ioachim; Rasmussen, Lars Hvilsted; Petrescu, Lucian; Crijns, Harry J. G. M; Tavazzi, Luigi; Maggioni, Aldo P; Lip, Gregory Y. H.. - In: SCIENTIFIC REPORTS. - ISSN 2045-2322. - 7:(2017), pp. 42379-42379. [10.1038/srep42379]
Corrigendum: Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes (Scientific Reports (2016) 6 (30271) DOI: 10.1038/srep30271)
BORIANI, Giuseppe;
2017
Abstract
This Article contains errors in the Acknowledgements section: "Abbott Vascular Int. (2011-2014), Amgen (2012-2018), AstraZeneca (2014-2017), Bayer (2013-2018), Boehringer Ingelheim (2013-2016), Boston Scientific (2010-2012), The Bristol Myers Squibb and Pfizer Alliance (2014-2016), The Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company (2014-2017), Gedeon Richter Plc. (2014-2017), Menarini Int. Op. (2010-2012), MSD-Merck & Co. (2011-2014), Novartis Pharma AG (2014-2017), ResMed (2014-2016), Sanofi (2010-2011), SERVIER (2012-2018)". should read: "Abbott Vascular Int. (2011-2014), Amgen (2009-2018), AstraZeneca (2014-2017), Bayer (2009-2018), Boehringer Ingelheim (2009-2016), Boston Scientific (2009-2012), The Bristol Myers Squibb and Pfizer Alliance (2011-2016), The Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company (2011-2017), Gedeon Richter Plc. (2014-2017), Menarini Int. Op. (2009-2012), MSD-Merck & Co. (2011-2014), Novartis Pharma AG (2014-2017), ResMed (2014-2016), Sanofi (2009-2011), SERVIER (2009-2018)".
| File | Dimensione | Formato | |
|---|---|---|---|
|
srep42379.pdf
Open access
Tipologia:
Versione pubblicata dall'editore
Dimensione
151.61 kB
Formato
Adobe PDF
|
151.61 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
